Search for: "DOW PHARMACEUTICAL SCIENCES, INC."
Results 81 - 100
of 131
Sorted by Relevance
|
Sort by Date
12 Oct 2021, 6:35 am
She has worked on many pharmaceutical products liability cases and acted as defense counsel for Merrell Dow Pharmaceuticals, Inc. [read post]
20 Apr 2017, 8:23 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579(1993). [read post]
5 Nov 2007, 12:58 pm
Merrell Dow Pharmaceuticals, Inc., 43 F.3d 1311, 1320 (9th Cir. 1995); DeLuca v. [read post]
18 Jan 2007, 10:48 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
11 May 2020, 1:09 am
In the words of Judge Jed Rakoff, who served on the President’s Council of Advisors on Science and Technology,[5] addressed the limited ability of cross-examination in the context of forensic evidence: “Although effective cross-examination may mitigate some of these dangers, the explicit premise of Daubert and Kumho Tire is that, when it comes to expert testimony, cross-examination is inherently handicapped by the jury’s own lack of background knowledge, so that the Court… [read post]
11 Nov 2021, 2:07 pm
Record-Setting Equity Markets and Low Litigation Rates During 3Q of 2021 and 4Q’s kick-off, liquidity permeates the capital markets leading public corporations trading in the U.S. markets to reach $50 trillion in aggregate market capitalization.[12] This is about $20 trillion more than one year ago (~67% increase in market cap during a global pandemic…) and the Federal Reserve is reluctant to restrict the money supply by keeping the federal funds rate at 0.25% while… [read post]
21 Jun 2011, 4:52 am
Merrell Dow Pharmaceuticals, Inc., 509 U. [read post]
4 Jul 2010, 4:16 pm
Merrell Dow Pharmaceuticals, Inc., 509 US 579 which, in federal courts, displaced the Frye general acceptance standard based upon the Federal Rules of Evidence. [read post]
16 Jun 2015, 7:22 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 593 (1993) (specifying the “the known or potential rate of error” as one of several factors in assessing the scientific reliability or validity of proffered expert witness’s opinion) Kumho Tire Co. v. [read post]
13 Jun 2017, 4:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), where the Supreme Court ruled that, under the federal evidence rules, “the trial judge must ensure that any and all scientific testimony or evidence admitted is not only relevant, but reliable” in light of several factors enumerated by the Court. [read post]
26 Oct 2009, 5:25 am
Medico (Filewrapper) BPAI finds claim indefinite and not directed to patentable subject under Bilski: Ex parte Hemmat (GRAY On Claims) District Court N D Illinois: KSR obviousness does not require prior art from the same field: Se-Kure Controls, Inc v Diam USA, Inc (Chicago Intellectual Property Law Blog) District Court E D Texas finds plaintiff has standing; agreement transfers ownership and simultaneously a conditional purchase by transferor from transferee: Balsam Coffee… [read post]
26 Oct 2009, 5:25 am
Medico (Filewrapper) BPAI finds claim indefinite and not directed to patentable subject under Bilski: Ex parte Hemmat (GRAY On Claims) District Court N D Illinois: KSR obviousness does not require prior art from the same field: Se-Kure Controls, Inc v Diam USA, Inc (Chicago Intellectual Property Law Blog) District Court E D Texas finds plaintiff has standing; agreement transfers ownership and simultaneously a conditional purchase by transferor from transferee: Balsam Coffee… [read post]
15 Dec 2009, 1:56 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993)]). [read post]
2 Nov 2018, 7:32 pm
Merrill Dow Pharmaceuticals, Inc., 874 F.2d 307, 311-12 (5th Cir. 1989) (“Fortunately, we do not have to resolve any of the above questions [as to bias and confounding], since the studies presented to us incorporate the possibility of these factors by the use of a confidence interval. [read post]
17 Jun 2021, 12:29 pm
Supreme Court breathed fresh life into the trial court’s power and obligation to review expert witness opinions and to exclude unsound opinions.[7] Several months before the Supreme Court charted this new direction on expert witness testimony, the silicone breast implant litigation, fueled by iffy science and iffier scientists, erupted.[8] In October 1994, the Judicial Panel on Multi-District Litigation created MDL 926, which consolidated the federal breast implant cases before Judge… [read post]
22 Jan 2019, 2:30 am
“Many of them are more concerned by what the court accepts as science rather than being motivated by science itself,” Dror said. [read post]
1 Jun 2014, 7:45 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), and Wilt v. [read post]
4 Oct 2007, 8:10 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), in which the Supreme Court first tried to evict "junk science," at least from the federal courts. [read post]
25 Apr 2015, 11:03 am
The first edition of the Reference Manual on Scientific Evidence [Manual] was published in 1994, a year after the Supreme Court delivered its opinion in Daubert. [read post]
10 Jun 2012, 1:09 pm
Merrell Dow Pharms., Inc., 874 F.2d 307, 311 (5th Cir. 1989) (noting that “[o]ne difficulty with epidemiologic studies is that often several factors can cause the same disease. [read post]
